Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $22 | $23 | $23 |
| % Growth | -99.3% | -2.1% | -2.3% | – |
| Cost of Goods Sold | $0 | $11 | $12 | $11 |
| Gross Profit | $0 | $11 | $11 | $12 |
| % Margin | 49.1% | 49.9% | 48.3% | 50.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $9 | $9 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $0 | $9 | $9 | $9 |
| Operating Income | -$0 | $2 | $2 | $2 |
| % Margin | -37.8% | 9.5% | 6.8% | 10.6% |
| Other Income/Exp. Net | $0 | $4 | $3 | $2 |
| Pre-Tax Income | $0 | $6 | $4 | $4 |
| Tax Expense | $0 | $1 | $1 | $1 |
| Net Income | $0 | $5 | $3 | $4 |
| % Margin | 13.8% | 20.4% | 13.8% | 15.5% |
| EPS | 0.53 | 107.87 | 72.91 | 82.99 |
| % Growth | -99.5% | 47.9% | -12.1% | – |
| EPS Diluted | 0.53 | 107.87 | 72.91 | 82.99 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $1 | $1 |
| EBITDA | $0 | $3 | $3 | $4 |
| % Margin | 20.5% | 14.7% | 11.9% | 15.2% |